Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature

Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature

Patients with non-small cell lung cancer (NSCLC) who carry epidermal growth factor receptor (EGFR) mutations can benefit significantly from EGFR tyrosine kinase inhibitors (EGFR TKIs). However, it is unclear whether patients without EGFR mutations cannot benefit from these drugs. Patient-derived tum...

Full description

Bibliographic Details
Main Authors: Yuetian Pan, Hongshang Cui, Yongbin Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
cancer
organoid
genetic analysis
lung cancer
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1109274/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1109274/full

Similar Items